Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)
Clinical trial NCT00941863 · COMPLETED
Trial details
- NCT number
- NCT00941863
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2005-05-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.